Variant report

Variant	nsv1050832
Chromosome Location	chr14:24458632-24489264
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:514)
CpG islands
(count:429)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:514 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr14:24483175-24483522	HepG2	liver:	n/a	n/a
2	ARID3A	chr14:24483172-24483507	K562	blood:	n/a	n/a
3	ATF2	chr14:24458816-24459305	GM12878	blood:	n/a	n/a
4	BACH1	chr14:24476252-24476312	H1-hESC	embryonic stem cell:	n/a	n/a
5	BATF	chr14:24458871-24459266	GM12878	blood:	n/a	n/a
6	BATF	chr14:24458905-24459223	GM12878	blood:	n/a	n/a
7	BHLHE40	chr14:24483187-24483465	GM12878	blood:	n/a	n/a
8	BHLHE40	chr14:24483227-24483438	K562	blood:	n/a	n/a
9	BHLHE40	chr14:24475943-24476541	HepG2	liver:	n/a	n/a
10	BRCA1	chr14:24483351-24483423	GM12878	blood:	n/a	n/a
11	CBX3	chr14:24476155-24476416	K562	blood:	n/a	n/a
12	CBX3	chr14:24483218-24483539	K562	blood:	n/a	n/a
13	CBX3	chr14:24483227-24483553	K562	blood:	n/a	n/a
14	CEBPB	chr14:24482978-24483461	A549	lung:	n/a	n/a
15	CEBPD	chr14:24475992-24476248	HepG2	liver:	n/a	n/a
16	CHD1	chr14:24483316-24483498	GM12878	blood:	n/a	n/a
17	CHD2	chr14:24483281-24483447	GM12878	blood:	n/a	n/a
18	CTCF	chr14:24483213-24483468	LNCaP	prostate:	n/a	n/a
19	CTCF	chr14:24483300-24483450	HCT-116	colon:	n/a	n/a
20	CTCF	chr14:24483280-24483430	GM12868	blood:	n/a	n/a
21	CTCF	chr14:24489140-24489290	GM12870	blood:	n/a	n/a
22	CTCF	chr14:24483179-24483486	Lung_OC	lung:	n/a	n/a
23	CTCF	chr14:24483142-24483498	T-47D	breast:	n/a	n/a
24	CTCF	chr14:24483206-24483477	K562	blood:	n/a	n/a
25	CTCF	chr14:24483199-24483448	Kidney_OC	kidney:	n/a	n/a
26	CTCF	chr14:24483260-24483410	GM12865	blood:	n/a	n/a
27	CTCF	chr14:24483260-24483410	HPF	lung:	n/a	n/a
28	CTCF	chr14:24458500-24458650	HEEpiC	esophagus:	n/a	n/a
29	CTCF	chr14:24483333-24483377	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr14:24483195-24483455	GM10266	blood:	n/a	n/a
31	CTCF	chr14:24483240-24483390	RPTEC	kidney:	n/a	n/a
32	CTCF	chr14:24483260-24483410	AoAF	blood vessel:	n/a	n/a
33	CTCF	chr14:24483240-24483390	AG09309	skin:	n/a	n/a
34	CTCF	chr14:24483240-24483390	HUVEC	blood vessel:	n/a	n/a
35	CTCF	chr14:24483198-24483471	HUVEC	blood vessel:	n/a	n/a
36	CTCF	chr14:24482812-24483817	A549	lung:	n/a	n/a
37	CTCF	chr14:24483260-24483410	HMF	breast:	n/a	n/a
38	CTCF	chr14:24483162-24483512	K562	blood:	n/a	n/a
39	CTCF	chr14:24483240-24483390	SAEC	small airway:	n/a	n/a
40	CTCF	chr14:24483280-24483430	GM12872	blood:	n/a	n/a
41	CTCF	chr14:24489260-24489510	NHEK	skin:	n/a	n/a
42	CTCF	chr14:24483150-24483513	K562	blood:	n/a	n/a
43	CTCF	chr14:24483196-24483488	MCF-7	breast:	n/a	n/a
44	CTCF	chr14:24483280-24483430	HEEpiC	esophagus:	n/a	n/a
45	CTCF	chr14:24483260-24483410	AG04449	skin:	n/a	n/a
46	CTCF	chr14:24483280-24483430	HBMEC	blood vessel:	n/a	n/a
47	CTCF	chr14:24483260-24483410	HUVEC	blood vessel:	n/a	n/a
48	CTCF	chr14:24483280-24483430	HAc	cerebellar:	n/a	n/a
49	CTCF	chr14:24483179-24483476	Medullo	brain:	n/a	n/a
50	CTCF	chr14:24483280-24483430	GM12870	blood:	n/a	n/a

(count:429 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:24473832-24473882	HNPCEpiC	eye:	n/a
2	chr14:24478620-24478670	ProgFib	skin:	n/a
3	chr14:24473832-24473882	HNPCEpiC	eye:	n/a
4	chr14:24478620-24478670	ProgFib	skin:	n/a
5	chr14:24478620-24478670	NB4	blood:	n/a
6	chr14:24476559-24476609	LNCaP	prostate:	n/a
7	chr14:24478620-24478670	SK-N-MC	brain:	n/a
8	chr14:24478620-24478670	BJ	skin:	n/a
9	chr14:24475053-24475103	MCF10A-Er-Src	breast:	n/a
10	chr14:24478620-24478670	MCF-7	breast:	n/a
11	chr14:24475906-24475956	GM12891	blood:	n/a
12	chr14:24475053-24475103	HNPCEpiC	eye:	n/a
13	chr14:24473832-24473882	AG09309	skin:	n/a
14	chr14:24476478-24476528	HAEpiC	amniotic membrane:	n/a
15	chr14:24476082-24476132	HCM	heart:	n/a
16	chr14:24476559-24476609	HRPEpiC	eye:	n/a
17	chr14:24476082-24476132	HRCEpiC	kidney:	n/a
18	chr14:24475053-24475103	Hela-S3	cervix:	n/a
19	chr14:24478620-24478670	IMR90	lung:	fetal
20	chr14:24476082-24476132	H1-hESC	embryonic stem cell:	embryo
21	chr14:24475053-24475103	GM12892	blood:	n/a
22	chr14:24478620-24478670	H1-hESC	embryonic stem cell:	embryo
23	chr14:24476478-24476528	AG10803	skin:	n/a
24	chr14:24476478-24476528	Jurkat	blood:	n/a
25	chr14:24473832-24473882	MCF10A-Er-Src	breast:	n/a
26	chr14:24473832-24473882	HCT-116	colon:	n/a
27	chr14:24476082-24476132	SAEC	small airway:	n/a
28	chr14:24476559-24476609	AG09319	gingival:	n/a
29	chr14:24475906-24475956	AoSMC	blood vessel:	n/a
30	chr14:24476082-24476132	SKMC	muscle:	n/a
31	chr14:24473832-24473882	MCF-7	breast:	n/a
32	chr14:24473832-24473882	A549	lung:	n/a
33	chr14:24476082-24476132	HIPEpiC	eye:	n/a
34	chr14:24476478-24476528	HNPCEpiC	eye:	n/a
35	chr14:24476559-24476609	NB4	blood:	n/a
36	chr14:24476478-24476528	ProgFib	skin:	n/a
37	chr14:24478620-24478670	SKMC	muscle:	n/a
38	chr14:24476082-24476132	LNCaP	prostate:	n/a
39	chr14:24475053-24475103	AG04450	lung:	fetal
40	chr14:24476478-24476528	LNCaP	prostate:	n/a
41	chr14:24475906-24475956	ProgFib	skin:	n/a
42	chr14:24475906-24475956	HPAEpiC	pulmonary alveolar:	n/a
43	chr14:24475906-24475956	MCF-7	breast:	n/a
44	chr14:24475053-24475103	RPTEC	kidney:	n/a
45	chr14:24476559-24476609	PrEC	prostate:	n/a
46	chr14:24475053-24475103	HCT-116	colon:	n/a
47	chr14:24476559-24476609	HIPEpiC	eye:	n/a
48	chr14:24473832-24473882	BJ	skin:	n/a
49	chr14:24476559-24476609	SK-N-MC	brain:	n/a
50	chr14:24476559-24476609	SK-N-SH	brain:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:24476695..24479385-chr14:24563251..24564763,2	MCF-7	breast:
2	chr14:24482946..24483934-chr14:24503845..24504435,3	MCF-7	breast:
3	chr14:24482858..24483785-chr14:24559502..24560237,2	K562	blood:
4	chr14:24482802..24483800-chr14:24505642..24506553,4	MCF-7	breast:
5	chr14:24483262..24483795-chr14:24906005..24906586,2	K562	blood:
6	chr14:24482840..24483718-chr14:24710880..24711620,2	MCF-7	breast:
7	chr14:24482659..24484974-chr14:24503307..24504865,2	MCF-7	breast:
8	chr14:24421533..24423333-chr14:24480435..24482151,2	K562	blood:
9	chr14:24483165..24483827-chr14:24559565..24560642,4	MCF-7	breast:

No data

Variant related genes	Relation type
DHRS4-AS1	TF binding region
DHRS4L2	TF binding region
DHRS4-AS1	CpG island
DHRS4L2	CpG island
ENSG00000215256	chromatin interactions
ENSG00000129535	chromatin interactions
ENSG00000225766	chromatin interactions
ENSG00000100889	chromatin interactions
ENSG00000157326	chromatin interactions
ENSG00000092330	chromatin interactions

Extended variants
information (count: 1504 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:1504 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs367560781	chr14:24458633-24458634	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs577577534	chr14:24458638-24458639	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs371471204	chr14:24458643-24458644	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs3783440	chr14:24458684-24458685	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs148676391	chr14:24458692-24458693	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs531691362	chr14:24458696-24458697	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs61999796	chr14:24458734-24458735	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs575960237	chr14:24458741-24458742	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs77491846	chr14:24458752-24458753	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
10	rs561626931	chr14:24458759-24458760	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs372372802	chr14:24458763-24458764	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs375472648	chr14:24458766-24458767	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs527412511	chr14:24458788-24458789	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs547175522	chr14:24458795-24458796	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs61999797	chr14:24458801-24458802	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs533030508	chr14:24458813-24458814	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs549669127	chr14:24458830-24458831	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs185551135	chr14:24458832-24458833	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs202112875	chr14:24458844-24458845	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs200360308	chr14:24458874-24458875	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs201153400	chr14:24458896-24458897	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs531604696	chr14:24458936-24458937	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs201793300	chr14:24458946-24458947	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs72692116	chr14:24458976-24458977	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs568445176	chr14:24458980-24458981	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs534302437	chr14:24459025-24459026	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs200223714	chr14:24459031-24459032	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs201754344	chr14:24459038-24459039	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs61999798	chr14:24459056-24459057	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs36064530	chr14:24459118-24459119	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs377217411	chr14:24459120-24459121	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs527371147	chr14:24459139-24459140	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs571056808	chr14:24459170-24459171	Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs549056371	chr14:24459206-24459207	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs189913915	chr14:24459245-24459246	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs182240901	chr14:24459247-24459248	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs576723560	chr14:24459261-24459262	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs541442184	chr14:24459267-24459268	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs555377084	chr14:24459273-24459274	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs61999799	chr14:24459275-24459276	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs540750390	chr14:24459306-24459307	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs563893043	chr14:24459309-24459310	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs367608971	chr14:24459339-24459340	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs370596373	chr14:24459351-24459352	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs373711317	chr14:24459367-24459368	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs201447616	chr14:24459379-24459380	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs201206047	chr14:24459387-24459388	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs529220393	chr14:24459392-24459393	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs371338153	chr14:24459394-24459395	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs145720846	chr14:24459396-24459397	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Cancer	20164920	CNVD
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16774939	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17440070	CNVD
Breast cancer	16272173	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Epilepsy	20736978	CNVD
Mental retardation	20736978	CNVD
severe speech impairment	20736978	CNVD
speech impairment	20736978	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic myeloid leukemia	20724749	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Cancer	21183584	CNVD
Leukoplakia	24403051	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	21364760	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Glioblastoma multiforme	21390271	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:564 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:24455800-24459400	Enhancers	Fetal Brain Female	brain
2	chr14:24456400-24459200	Weak transcription	Brain Cingulate Gyrus	brain
3	chr14:24457400-24459000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr14:24457400-24459200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr14:24457600-24458800	Flanking Active TSS	Fetal Muscle Leg	muscle
6	chr14:24457600-24459000	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
7	chr14:24457600-24459000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
8	chr14:24457600-24459000	Flanking Active TSS	Fetal Thymus	thymus
9	chr14:24457600-24459000	Flanking Active TSS	Dnd41	blood
10	chr14:24457600-24459600	Enhancers	Spleen	Spleen
11	chr14:24457800-24458800	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr14:24457800-24458800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
13	chr14:24457800-24458800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr14:24457800-24459000	Active TSS	Brain Hippocampus Middle	brain
15	chr14:24457800-24459000	Active TSS	GM12878-XiMat	blood
16	chr14:24457800-24459600	Enhancers	Fetal Brain Male	brain
17	chr14:24458000-24458800	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
18	chr14:24458000-24458800	Active TSS	Primary T cells from cord blood	blood
19	chr14:24458000-24458800	Flanking Active TSS	Liver	Liver
20	chr14:24458200-24458800	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
21	chr14:24458200-24458800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr14:24458200-24458800	Flanking Active TSS	Pancreas	Pancrea
23	chr14:24458200-24459000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr14:24458200-24459200	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
25	chr14:24458200-24459400	Flanking Active TSS	Duodenum Mucosa	Duodenum
26	chr14:24458200-24459400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
27	chr14:24458200-24459400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
28	chr14:24458200-24459400	Enhancers	Stomach Mucosa	stomach
29	chr14:24458200-24459600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
30	chr14:24458400-24458800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr14:24458400-24458800	Enhancers	Primary B cells from cord blood	blood
32	chr14:24458400-24458800	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
33	chr14:24458400-24458800	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
34	chr14:24458400-24458800	Flanking Active TSS	Psoas Muscle	Psoas
35	chr14:24458400-24458800	Flanking Active TSS	Rectal Smooth Muscle	rectum
36	chr14:24458400-24458800	Flanking Active TSS	Stomach Smooth Muscle	stomach
37	chr14:24458400-24458800	Flanking Active TSS	Thymus	Thymus
38	chr14:24458400-24459000	Enhancers	Primary T helper cells PMA-I stimulated	--
39	chr14:24458400-24459000	Enhancers	Lung	lung
40	chr14:24458400-24459000	Flanking Active TSS	A549	lung
41	chr14:24458400-24459200	Enhancers	Primary B cells from peripheral blood	blood
42	chr14:24458400-24459200	Enhancers	Fetal Lung	lung
43	chr14:24458400-24459600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr14:24458600-24458800	Enhancers	Primary hematopoietic stem cells	blood
45	chr14:24458600-24458800	Enhancers	Primary T helper cells fromperipheralblood	blood
46	chr14:24458600-24458800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
47	chr14:24458600-24458800	Enhancers	Fetal Intestine Small	intestine
48	chr14:24458600-24458800	Enhancers	Gastric	stomach
49	chr14:24458600-24458800	Enhancers	Right Atrium	heart
50	chr14:24458600-24458800	Enhancers	Right Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links